 Morphic NASDAQ:MORF was upgraded by Zacks Investment Research from a hold rating to a buy rating in a research note issued on Thursday, Zacks.com reports. The firm presently has a 15.00 price objective on the stock. Zacks Investment Researchs target price suggests a potential upside of 9.49 from the stocks previous close. According to Zacks, ... 